Cargando…
The making of bispecific antibodies
During the past two decades we have seen a phenomenal evolution of bispecific antibodies for therapeutic applications. The ‘zoo’ of bispecific antibodies is populated by many different species, comprising around 100 different formats, including small molecules composed solely of the antigen-binding...
Autores principales: | Brinkmann, Ulrich, Kontermann, Roland E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297537/ https://www.ncbi.nlm.nih.gov/pubmed/28071970 http://dx.doi.org/10.1080/19420862.2016.1268307 |
Ejemplares similares
-
The eIg technology to generate Ig-like bispecific antibodies
por: Kühl, Lennart, et al.
Publicado: (2022) -
Influence of antigen density and immunosuppressive factors on tumor-targeted costimulation with antibody-fusion proteins and bispecific antibody-mediated T cell response
por: Sapski, Sabrina, et al.
Publicado: (2020) -
Format and geometries matter: Structure-based design defines the functionality of bispecific antibodies
por: Dickopf, Steffen, et al.
Publicado: (2020) -
A scDb-based trivalent bispecific antibody for T-cell-mediated killing of HER3-expressing cancer cells
por: Aschmoneit, Nadine, et al.
Publicado: (2021) -
Mammalian Display Platform for the Maturation of Bispecific TCR-Based Molecules
por: Dilchert, Janine, et al.
Publicado: (2022)